Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
clinical trials
glaxosmithkline
3
×
life sciences
national blog main
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san francisco blog main
san francisco top stories
amgen
avexis
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
brian kaspar
centers for disease control and prevention
detroit blog main
detroit top stories
fda
indiana blog main
indiana top stories
medical device
national
national top stories
novartis
san diego blog main
san diego top stories
satsuma pharmaceuticals
seattle blog main
seattle top stories
springworks therapeutics
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
zolgensma
10x genomics
What
biotech
3
×
days
news
roundup
according
activity
akcea
august
bio
busy
cases
centers
cigarettes
companies
control
deaths
decisions
devices
disease
dog
drug
drugs
electronic
fda
firm
hasn’t
including
injuries
ipo
ipos
leading
legacy
line
linked
lung
migraine
nash
nods
opioid
past
Language
unset
Current search:
glaxosmithkline
×
biotech
×
@xconomy.com
4 years ago
Biotech Roundup: Vaping Toll Rises, NASH News, Akcea Shakeup & More
@xconomy.com
4 years ago
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More
@xconomy.com
4 years ago
Pfizer Spinout SpringWorks, Migraine Drug Firm Satsuma Prep IPOs
